According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current EPS (TTM) is $3.76. In 2022 the company made an earnings per share (EPS) of $4.02 an increase over its 2021 EPS that were of $3.21.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.76 | -6.44% |
2022 | $4.02 | 25.2% |
2021 | $3.21 | 151.46% |
2020 | $1.28 | 61.5% |
2019 | $0.79 | 86.18% |
2018 | $0.42 | 8.45% |
2017 | $0.39 | -33.39% |
2016 | $0.59 | 32.84% |
2015 | $0.44 | -30.76% |
2014 | $0.64 | 4.36% |
2013 | $0.61 | 1.46% |
2012 | $0.60 | 2.3% |
2011 | $0.59 | -6.4% |
2010 | $0.63 |